Evaluation of Ivacaftor in Patients Using Ataluren for Nonsense Mutations

Summary

The purpose of this study is to explore the combination of Ataluren and ivacaftor as a treatment for patients with a specific cystic fibrosis mutation

Timeline

Start

2017-03-17

Primary completion

2017-07-10

Completion

2018-02-16

Drugs

Indications